Prøve GULL - Gratis
LUPUS IN FOCUS: NAVIGATING DELAYED DIAGNOSIS AND EMERGING TREATMENTS
Healthcare Radius
|September 2025
As science continues to unravel the complexities of lupus and healthcare systems modernize, the vision of transforming lupus into a predictable, controllable, and perhaps curable disease is within reach.

Systemic lupus erythematosus (SLE), commonly referred to simply as lupus, is a chronic, multi-system autoimmune disorder that remains both a fascinating medical challenge and a pressing public health concern.
It is a condition where the body's immune system designed to protect against infections turns against its own cells and tissues. This misguided response can affect virtually any organ, from the skin and joints to the kidneys, heart, lungs, and brain.
The name lupus dates back to the 13th century, derived from the Latin word for "wolf," referring to the facial rash thought to resemble a wolf's bite, and erythematosus meaning "redness." While the historical name evokes imagery, the modern medical understanding is rooted in immunology and molecular science. Today, lupus is recognized not as an immune deficiency but as an abnormal immune response triggered by a combination of genetic predisposition, environmental exposures, and immune dysregulation.
Epidemiology and Patient Profile
Lupus affects people of all ages, though it is most common in women of childbearing age, between 15 and 40 years. The female-to-male ratio is striking approximately 9:1 likely due to hormonal influences, particularly estrogen. While global prevalence varies, estimates suggest that 20-150 per 100,000 people are affected, with higher rates in certain ethnic groups, including Asians, Africans, and Hispanics.
In India, lupus is underdiagnosed, partly because of limited epidemiological studies, fragmented healthcare access, and low awareness among both the public and nonspecialist clinicians. In many cases, patients endure years of vague symptoms before a definitive diagnosis is made.
Denne historien er fra September 2025-utgaven av Healthcare Radius.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Healthcare Radius

Healthcare Radius
ASTER DM HEALTHCARE EXPANDS BENGALURU FOOTPRINT WITH RS 580 CRORE HOSPITAL
Aster DM Healthcare has announced an Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.
1 min
September 2025

Healthcare Radius
COULD DONALD TRUMP'S TRADE MOVES HIT INDIA'S PHARMA EXPORTS NEXT?
If tariffs hit, medicines could cost more in the U.S., and India's drug industry could take a hit. For now, it's all talk, but India's pushing for trade deals and new markets to stay strong.
3 mins
September 2025

Healthcare Radius
HCG TREATS 33-YR-OLD PATIENT WITH SCARLESS CANCER SURGERY
HCG Manavata Cancer Centre (HCGMCC) successfully performed a scarless intraoral surgery on a 33-year-old male diagnosed with buccal mucosa (cheek) cancer.
1 min
September 2025

Healthcare Radius
CELCIUS LOGISTICS LAUNCHES PHARMA COLD CHAIN ARM WITH RS 50CR INVESTMENT
Celcius Logistics has announced the launch of Celcius+, a specialised logistics arm dedicated exclusively to the seamless management of the pharmaceutical supply chain.
1 min
September 2025

Healthcare Radius
PFIZER LAUNCHES 20-VALENT PNEUMONIA VACCINE FOR ADULTS IN INDIA
Pfizer announced the launch of its nextgeneration 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITAL APPOINTS DR. SURENDER DABAS TO LEAD ROBOTIC CANCER CARE IN DELHI
Manipal Hospital welcomes one of India's most renowned and celebrated robotic onco-surgeons, Dr. Surender Kumar Dabas, as Chairman – Manipal Comprehensive Cancer Centre and Onco Robotic Surgeries, North-West Cluster.
1 min
September 2025

Healthcare Radius
ZYDUS RECEIVES USFDA APPROVAL FOR CONSTIPATION DRUG PRUCALOPRIDE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity Ⓡ Tablets, 1mg and 2 mg).
1 min
September 2025

Healthcare Radius
SSI PERFORMS WORLD'S FIRST CARDIAC TELESURGERY ACROSS 10,000 KM
SS Innovations International, Inc. has achieved a historic milestone at the Annual Conference of the Society of Robotic Surgery (SRS) in Strasbourg, France, with the successful completion of two complex transcontinental robotic telesurgeries using the indigenously developed SSI Mantra Surgical Robotic System.
1 min
September 2025

Healthcare Radius
MANIPAL HOSPITALS SIGNS MOU WITH MAHA GOVT TO INVEST RS 700CR IN NEW NAGPUR HOSPITAL
Manipal Hospitals has signed a Memorandum of Understanding (MoU) with the Government of Maharashtra to build a state-of-the-art 350-bed multi-speciality Hospital at Nagpur.
1 min
September 2025

Healthcare Radius
INSIDE INDIA'S AMR CHALLENGE: FIXING AWARENESS, DIAGNOSTICS AND HOSPITAL POLICY GAPS
Dr. Narendra Saini of the IMA unpacks India's escalating AMR crisis, highlighting solutions to bridge awareness, diagnostics and policy gaps in the fight against a looming public health threat.
9 mins
September 2025
Listen
Translate
Change font size